Reasons to Retain Revvity (RVTY) Stock in Your Portfolio Now
https://www.zacks.com/stock/news/2296489/reasons-to-retain-revvity-rvty-stock-in-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2296489
Jul 03, 2024 - Revvity's (RVTY) strong product portfolio raises optimism about the stock.
0
Here's Why You Should Retain Glaukos (GKOS) Stock for Now
https://www.zacks.com/stock/news/2296487/here-s-why-you-should-retain-glaukos-gkos-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2296487
Jul 03, 2024 - Glaukos (GKOS) continues to benefit from a robust product portfolio and favorable clinical trial results.
0
Freeport (FCX) Starts Commissioning of New Indonesian Smelter
https://www.zacks.com/stock/news/2296459/freeport-fcx-starts-commissioning-of-new-indonesian-smelter?cid=CS-ZC-FT-analyst_blog|company_news_corporate_actions-2296459
Jul 03, 2024 - Freeport (FCX) anticipates that the smelter will begin producing copper cathodes in the following months and that it will reach full ramp-up by the end of 2024.
0
Avantor (AVTR) Launches Solutions for Gene Therapy Harvest
https://www.zacks.com/stock/news/2296313/avantor-avtr-launches-solutions-for-gene-therapy-harvest?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2296313
Jul 02, 2024 - Avantor's (AVTR) solutions are intended to provide gene therapy manufacturers with sustainable and efficient alternatives to traditional methods, thus improving viral particle harvest and quality
0
Masimo's (MASI) WI Sport Wearable Gets a New Powerful Feature
https://www.zacks.com/stock/news/2296309/masimo-s-masi-wi-sport-wearable-gets-a-new-powerful-feature?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2296309
Jul 02, 2024 - Masimo (MASI) announces Sleep Halo, a new feature for its Masimo W1 Sport advanced health tracking wearable.
0
Reasons to Retain PacBio (PACB) Stock in Your Portfolio Now
https://www.zacks.com/stock/news/2296273/reasons-to-retain-pacbio-pacb-stock-in-your-portfolio-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2296273
Jul 02, 2024 - PacBio's (PACB) strong product demand and continued focus on R&D raise optimism about the stock.
0
Nexa Resources (NEXA) Sells Morro Agudo Complex to Casa Verde
https://www.zacks.com/stock/news/2296093/nexa-resources-nexa-sells-morro-agudo-complex-to-casa-verde?cid=CS-ZC-FT-analyst_blog|company_news_corporate_actions-2296093
Jul 02, 2024 - Nexa Resources (NEXA) sells its Morro Agudo Complex to optimize its portfolio.
0
Air Liquide's (AIQUY) Transformation Plan to Drive Efficiency
https://www.zacks.com/stock/news/2296175/air-liquide-s-aiquy-transformation-plan-to-drive-efficiency?cid=CS-ZC-FT-analyst_blog|company_news_corporate_actions-2296175
Jul 02, 2024 - Air Liquide's (AIQUY) strong business model and successful implementation of its ADVANCE strategic plan have put the company in on a solid footing.
0
PacBio (PACB) and Form Bio to Boost AAV Industry Development
https://www.zacks.com/stock/news/2295819/pacbio-pacb-and-form-bio-to-boost-aav-industry-development?cid=CS-ZC-FT-analyst_blog|company_news_medical_sector-2295819
Jul 01, 2024 - PacBio (PACB) and Form Bio collaborate to form an expert AAV Working Group to introduce essential tools for AAV development and research professionals.
0
CalMaine Foods (CALM) Acquires ISE America Assets for $110M
https://www.zacks.com/stock/news/2295438/calmaine-foods-calm-acquires-ise-america-assets-for-110m?cid=CS-ZC-FT-analyst_blog|company_news_corporate_actions-2295438
Jul 01, 2024 - CalMaine Foods (CALM) buys assets of ISE to boost market reach in the Northeast and Mid-Atlantic states.
0